0001666071-21-000088.txt : 20210511 0001666071-21-000088.hdr.sgml : 20210511 20210511183224 ACCESSION NUMBER: 0001666071-21-000088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210507 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christiansen Andrew CENTRAL INDEX KEY: 0001805400 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 21912864 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_162077232536742.xml FORM 4 X0306 4 2021-05-07 0 0001666071 Cardlytics, Inc. CDLX 0001805400 Christiansen Andrew C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 0 1 0 0 Chief Financial Officer Common Stock 2021-05-07 4 S 0 287 99.93 D 15560 D Common Stock 2021-05-07 4 S 0 1000 100.98 D 14560 D Common Stock 2021-05-07 4 S 0 850 102.25 D 13710 D Common Stock 2021-05-07 4 S 0 550 103.46 D 13160 D Common Stock 2021-05-07 4 S 0 204 104.02 D 12956 D Common Stock 2021-05-07 4 S 0 50 105.15 D 12906 D Common Stock 2021-05-10 4 S 0 250 98.25 D 12656 D Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.59 to $100.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5) and (6) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.61 to $101.55, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.93 to $102.83, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $102.99 to $103.98, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $104.01 to $104.06, inclusive. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. /s/ Kirk L. Somers, Attorney-in-Fact 2021-05-11